TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 171 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,712,460 | -69.0% | 254,000 | -71.0% | 0.03% | -65.6% |
| Q4 2022 | $18,443,310 | -1.0% | 877,000 | +16.0% | 0.09% | -1.1% |
| Q3 2022 | $18,628,000 | +147.6% | 756,000 | +143.5% | 0.09% | +175.8% |
| Q2 2022 | $7,523,000 | +35.5% | 310,500 | +44.1% | 0.03% | +73.7% |
| Q1 2022 | $5,553,000 | -66.1% | 215,500 | -59.2% | 0.02% | -45.7% |
| Q4 2021 | $16,389,000 | +150.7% | 528,000 | +95.8% | 0.04% | +118.8% |
| Q3 2021 | $6,538,000 | +64.8% | 269,600 | -0.9% | 0.02% | +77.8% |
| Q2 2021 | $3,968,000 | – | 272,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |